Document is current

Article History

Received: 30 September 2018

Accepted: 3 May 2019

First Online: 24 May 2019

Authors’ information

: ADW had the idea for this trial, has been coordinating the protocol development, is the coordinating investigator and responsible for the present paper. She is a senior lecturer and consultant at the University Hospital of Lausanne, where she is head of the upper gastrointestinal cancer unit in the department of oncology. In addition, she is chair of the EORTC GI GROUP gastric task force (together with MHM).

: This study protocol has been approved by the competent ethics committees in all participating countries as requested by the applicable national legislation. Full names of the ethics committees, including the institution to which it belong, as well as approval dates and reference numbers of all ethics approvals are listed on the supplementary file. It is conducted in agreement with either the Declaration of Helsinki (available on the World Medical Association web site [CitationRef removed]) and/or the laws and regulations of the country, whichever provides the greatest protection of the patient as well as according to the ICH Harmonized Tripartite Guideline on Good Clinical Practice (ICH-GCP), available online at [CitationRef removed]. All patients gave written informed consent to participate.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.